Epoetin β pegol (continuous erythropoietin receptor activator, CERA) is another choice for the treatment of anemia in myelodysplastic syndrome: a case report
Crossref DOI link: https://doi.org/10.1186/s13256-017-1468-z
Published Online: 2017-10-19
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ikenoue, Tatsuyoshi
Naito, Hiroshi
Kitamura, Tetsuya
Hattori, Hideki